Hydroxylase and catalytic application method thereof
By mining and screening high-active and highly selective cis-4-proline hydroxylase in the NCBI database, the unstable and poor selective expression of proline hydroxylase in heterogeneous expression was solved. The problem of this paper has achieved efficient and highly selective cis-L-5-hydroxy-piperidine-2-formic acid synthesis, with high industrial application potential.
Patent Information
- Application Number
- CN202411364935.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-27
- Publication Date
- 2024-12-03
AI Technical Summary
The existing proline hydroxylase is unstable in the expression of active and soluble proteins during heterogeneous expression, and has poor selectivity, resulting in high cost of industrial application, especially in the production of cis-5-hypip, resulting in high separation costs.
By mining cis-4-proline hydroxylase from multiple sources in the NCBI database, heterologous expression and horizontal comparison were performed, and the expression level of soluble active proteins in E. coli was optimized, and high activity and high selectivity were screened. cis-4-proline hydroxylase was prepared by recombinant vectors and genetically engineered bacteria, and the catalytic reaction was used to synthesize cis-L-5-hydroxy-piperidine-2-carboxylic acid.
It has achieved efficient and selective synthesis of cis-L-5-hydroxy-piperidine-2-carboxylic acid, mild reaction conditions, high raw material utilization rate, high industrial application potential, and reduced production costs.
Smart Images

Figure CN119060972A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of bioengineering, in particular to hydroxylase and a catalytic application method thereof. Background Art
[0002] In current industrial organic synthesis, the oxidation of inactive CH bonds is a very important reaction. Currently, the oxidation of inactive CH bonds requires the use of protective groups, which is a complex process and requires a large amount of organic reagents, high energy consumption and high pollution. The use of biocatalytic methods to oxidize inactive CH can avoid this problem. At the same time, biocatalysts have high selectivity and can greatly reduce the production of product isomers. Proline hydroxylase is a specific Fe-dependent 2+ Proline hydroxylase is a mononuclear non-heme dioxygenase that catalyzes the production of α-ketoglutarate and hydroxylation, desaturation, epoxidation, desulfurization, halogenation, and cyclization to form peroxides on inactive CH bonds of substrates. Hydroxylases are also involved in the synthesis of some important secondary metabolites, such as β-lactam antibiotics, flavonoids, alkaloids, and gibberellins. Based on the diversity of its catalytic reactions, proline hydroxylase is widely used in the catalytic conversion of various chiral synthetic building blocks such as cis-L-5-hydroxy-L-pipecolic acids (cis-5-hypip).
[0003] From the cost aspect, as a proline hydroxylase that can be promoted for the production of chiral synthetic building blocks, it is expected that the enzyme protein can be expressed in the form of active enzyme and soluble protein in industry through heterologous hosts such as Escherichia coli. However, when expressing proline hydroxylase using heterologous expression systems, there are often cases where the enzyme is naturally active but not expressed in the form of active enzyme, or the soluble protein is naturally expressed in the form of insoluble protein. At the same time, the proline hydroxylases currently under study still have problems such as poor selectivity. Taking the production of cis-5-hypip as an example, most proline hydroxylases have poor selectivity for cis-5-hypip and cis-3-hypip, which are basically 1:1, resulting in high subsequent separation costs. Therefore, exploring and screening highly active and highly selective proline hydroxylases will help greatly enhance their industrialization potential. Summary of the invention
[0004] To solve the above problems, the present invention provides a method for screening, preparing and catalytic application of high-performance hydroxylase. By comparing genes in the NCBI database, cis-4-proline hydroxylases from various sources were excavated, and heterologous expression was performed on them. The expression levels of soluble active proteins were analyzed horizontally, and cis-4-proline hydroxylase (WP_046758372.1, kjP4H) from Kordia jejudonensis was obtained. It can be efficiently heterologously expressed in Escherichia coli, has a high enzyme activity level, and has high selectivity for cis-5-hypip.
[0005] The technical solution of the present invention to solve the above problems is as follows:
[0006] The present invention provides a cis-4-proline hydroxylase, wherein the amino acid sequence of the cis-4-proline hydroxylase is shown in SEQ ID NOs. 1 to 8; the nucleotide sequence of the gene encoding the cis-4-proline hydroxylase is shown in SEQ ID NOs. 9 to 16.
[0007] The biological source of the cis-4-proline hydroxylase is as follows:
[0008] Table 1: Biological sources of the above cis-4-proline hydroxylases
[0009]
[0010] Preferably, the cis-4-proline hydroxylase is derived from any one of Mesorhizobium sp., Sinorhizobiummeliloti (Rhizobium meliloti), Mesorhizobium japonicum, Kordia jejudonensis, Sinorhizobium meliloti, Micromonospora chokoriensis, Xenorhabdus doucetiae, and Segniliparus rugosus. Its functions include L-piperidinic acid 5'- / 3' hydroxylation function, and it can be heterologously expressed using a heterologous host Escherichia coli BL21.
[0011] The present invention also provides a recombinant vector, which contains the above-mentioned coding gene.
[0012] Preferably, the recombinant vector is pET-28a(+).
[0013] The present invention also provides a genetically engineered bacterium into which the above-mentioned recombinant vector is introduced.
[0014] Preferably, the genetically engineered bacteria is E. coli BL21 (DE3).
[0015] The present invention also provides the use of the cis-4-proline hydroxylase in the preparation of cis-L-5-hydroxy-piperidine-2-carboxylic acid.
[0016] Preferably, L-piperidinic acid is used as a substrate, α-ketoglutaric acid is used as a cosubstrate, and the above-mentioned cis-4-proline hydroxylase is used as a catalyst to carry out a catalytic reaction in a system containing ferrous salts, antioxidants, and buffer to synthesize cis-L-5-hydroxy-piperidine-2-carboxylic acid.
[0017] Preferably, the amount of cis-4-proline hydroxylase added does not exceed 10w% of the reaction system.
[0018] Preferably, the catalyst comprises cells or microorganisms capable of producing cis-4-proline hydroxylase; the addition amount of the cells or microorganisms is 10 to 150 g / L.
[0019] Preferably, the concentrations of the L-piperidinic acid and the α-ketoglutaric acid are both 10 to 180 mmol / L.
[0020] Preferably, the ferrous salt is selected from one or more of ferrous chloride, ferrous sulfate and ammonium ferrous nitrate.
[0021] Preferably, the concentration of the ferrous salt is 1-6 mmol / L.
[0022] Preferably, the antioxidant is selected from at least one of ascorbic acid and ascorbate. The addition of antioxidant can prevent the Fe 2+ Oxidized.
[0023] Preferably, the antioxidant concentration is 5 to 20 mmol / L.
[0024] Preferably, the temperature of the catalytic reaction is 25-55° C.; the pH of the catalytic reaction is 6.0-7.5.
[0025] Preferably, the buffer is selected from one or more of K2HPO4-KH2PO4, Tris-HCl and HEPES-NaOH buffer.
[0026] Figure 4 The mechanism diagram of the above catalytic reaction; in the figure, Asp, His, and His are residues in the cis-4-proline hydroxylase (cis-P4H) protein, which react with α-ketoglutarate (α-KG) and H2O in the reaction medium to form a catalytic reaction. 2+ Form coordination bonds to anchor Fe2+ position, while protecting Fe 2+ Prevent it from being oxidized; after the reaction starts, the O2 in the reaction medium replaces the H2O and Fe 2+ Forming coordination bonds, cis-P4H utilizes O2 and Fe 2+ Decompose α-ketoglutarate into SA (succinic acid) and CO2, and generate highly active iron-based (Fe 4+ =O), highly active iron-based (Fe 4+ =O) extracts hydrogen radicals from C4 of L-PA to generate Fe 3+ -OH intermediates and L-PA radicals, Fe 3+ The -OH group of -OH couples with the L-PA radical to form cis-5-Hypip and regenerate Fe 2+ The initial oxidation state.
[0027] Since a large amount of insoluble proteins exist in the heterologous expression process of cis-4-proline hydroxylases from different sources in E. coli BL21 (DE3), it is necessary to optimize the expression conditions of proline hydroxylases from various sources. Therefore, the present invention also provides a method for determining the specific enzyme activity of cis-4-proline hydroxylases:
[0028] Using L-piperidinic acid as a substrate, α-ketoglutaric acid as a cosubstrate, and cis-4-proline hydroxylase or cells / microorganisms capable of producing cis-4-proline hydroxylase as catalysts, a catalytic reaction is carried out in a system containing ferrous salts, antioxidants, and buffer, and the reaction solution is derivatized and then detected by HPLC.
[0029] Preferably, the cis-4-proline hydroxylase participates in the catalytic reaction of synthesizing cis-L-5-hydroxy-piperidine-2-carboxylic acid in the following forms: wet bacterial cells of the genetically engineered bacteria of the cis-4-proline hydroxylase, cell disruption liquid expressing cis-4-proline hydroxylase, or pure enzyme liquid separated after cell disruption and protein purification of wet bacterial cells of the genetically engineered bacteria of the cis-4-proline hydroxylase.
[0030] The wet bacteria were prepared as follows: the genetically engineered bacteria containing cis-4-proline hydroxylase were inoculated into LB liquid culture medium, which contained a final concentration of 50 μg / mL kanamycin antibiotics as a basic indicator for engineering strain screening, and were cultured in a 37°C shaker for 8 to 14 hours. After the culture was completed, 1% to 3% of the inoculation amount was inoculated into a fresh LB culture medium that had been autoclaved at 121°C for 20 minutes, and cultured at 37°C 200rpm for 1.5 to 2.5 hours until the OD 6000.4~0.6, add IPTG with a final concentration of 0.1mM to the culture medium, and then culture it at 20℃ for 20h. After the culture is completed, centrifuge the culture medium at 4℃ and 8000rpm for 10min to obtain wet bacteria containing cis-4-proline hydroxylase gene.
[0031] The present invention has the following beneficial effects:
[0032] The present invention establishes a method for determining the relative enzymatic activity of cis-4-proline hydroxylase, which can be used to screen cis-4-proline hydroxylases with high enzymatic activity and stereoselectivity. Cis-4-proline hydroxylases from various biological sources are screened, and a cis-4-proline hydroxylase that can be efficiently heterologously expressed in Escherichia coli and has high selectivity for cis-5-hypip is obtained. As a catalyst, it can be used to catalyze the synthesis of cis-L-5-hydroxy-piperidine-2-carboxylic acid with high yield and high selectivity. The synthesis method has mild reaction conditions, high raw material utilization rate and is relatively environmentally friendly, and has certain industrial application potential. BRIEF DESCRIPTION OF THE DRAWINGS
[0033] Figure 1 It is a plasmid vector containing the cis-4-proline hydroxylase gene, i.e., pET28a(+)-P4H;
[0034] Figure 2 The SDS-PAGE gel images of cis-4-proline hydroxylase from different sources expressed at 20°C (the molecular weight of cis-P4H protein is about 32 kDa; Figure 2-1 Lanes 1 and 2 in the middle are the supernatant and precipitate of SmlP4H; Lanes 3 and 4 are the supernatant and precipitate of SmP4H; Lanes 5 and 6 are the supernatant and precipitate of MIP4H; Lanes 8 and 9 are the supernatant and precipitate of MjP4H; Lanes 10 and 11 are the supernatant and precipitate of KjP4H; Figure 2-2 The middle lanes 1.2 are the supernatant and precipitate of SruP4H; lanes 3 and 4 are the supernatant and precipitate of McP4H; lanes 5 and 6 are the supernatant and precipitate of XdP4H);
[0035] Figure 3 The reaction scheme for the synthesis of cis-L-5-hydroxy-piperidine-2-carboxylic acid (cis-5-hypip) catalyzed by cis-4-proline hydroxylase (cis-P4H);
[0036] Figure 4 The reaction mechanism diagram of the synthesis of cis-L-5-hydroxy-piperidine-2-carboxylic acid (cis-5-hypip) catalyzed by cis-4-proline hydroxylase;
[0037] Figure 5The reaction process diagram for generating cis-5-hypip in Examples 4 to 7;
[0038] Figure 6 This is a reaction process diagram for generating cis-3-hypip in Examples 4 to 7. DETAILED DESCRIPTION
[0039] In order to make the purpose, technical scheme and advantages of the present invention more clear, the present invention is further described in detail in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention, rather than all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.
[0040] The inoculation, transfer, induction and cell recovery of the engineered bacteria containing the cis-4-proline hydroxylase gene of the present invention can be any culture medium in the art that can grow the bacteria and produce the present invention, preferably LB culture medium: 10 g / L tryptone, 5 g / L yeast extract, 5 g / L NaCl, dissolved in distilled water, and adjusted to pH 7.0. There are no special restrictions on the culture method and culture conditions, and the culture method and conditions can be appropriately selected according to the common knowledge in the art based on factors such as the host type and the culture method.
[0041] Example 1: Construction of a recombinant plasmid expressing lysine cyclodeaminase
[0042] Mesorhizobium sp., Sinorhizobium meliloti (Rhizobium meliloti), Mesorhizobium japonicum, Kordia jejudonensis, Sinorhizobium meliloti, Micromonospora chokoriensis, Xenorhabdus doucetiae, Segniliparus were artificially synthesized in the form of gene sequences (SEQ ID NOs. 9 to 16) that were codon-optimized for expression in E. coli. rugosus, with XhoI and NcoI restriction sites added at both ends, and the gene fragment was inserted into the corresponding restriction sites of the expression vector pET-28a(+) through double enzyme digestion and ligation, and placed under the control of T7 promoter to obtain recombinant plasmids: pET-28a(+)-MlP4H, pET-28a(+)-SmP4H, pET-28a(+)-MjP4H, pET-28a(+)-KjP4H, pET-28a(+)-SmlP4H, pET-28a(+)-McP4H, pET-28a(+)-XdP4H, pET-28a(+)-SruP4H.
[0043] Example 2: Obtaining cis-4-proline hydroxylase gene expressing bacteria
[0044] Using the plasmids obtained in Example 1, Escherichia coli BL21 (DE3) was transformed according to a conventional method. The transformation steps were as follows: the obtained mutant plasmid was transferred into E. coli BL21 (DE3) competent cells by heat shock at 42° C., the obtained strain was inoculated, transferred, induced, and the bacterial cell was recovered, and the substrate L-piperidinic acid was catalyzed by the resuspended bacterial liquid to prepare cis-5-hypip. The specific method is as follows: cis-4-proline hydroxylase was activated to obtain engineered strains E. coli BL21 (D E3) / pET-28a (+) -MlP4H, E. coli BL21 (DE3) / pET-28a (+) -SmP4H, E. coli BL21 (D E3) / pET-28a (+) -MjP4H, E. coli BL21(DE3) / pET-28a(+)-KjP4H, E. coli BL21(D E3) / pET-28a(+)-SmlP4H, E. coli BL21(DE3) / pET-28a(+)-McP4H, E. coli BL21(D E3) / pET-28a(+)-XdP4H, E. coli BL21(DE3) / pET-28a(+)-SruP4H, extract plasmids pET-28a(+)-MlP4H, pET-28a(+)-SmP4H, pET-28a(+)-MjP4H, pET-28a(+)-KjP4H, pE T-28a(+)-SmlP4H, pET-28a(+)-McP4H, pET-28a(+)-XdP4H, pET-28a(+)-SruP4H, and stored at -20°C.
[0045] Example 3: Determination of the specific enzyme activity of cis-4-proline hydroxylase from different sources
[0046] The recombinant engineered strain obtained in Example 2 was expanded and transferred to a test tube containing 10 mL of LB liquid medium (50 μg / mL kanamycin). After culturing at 37°C and 180 rpm for 10 h, 1 mL of the bacterial solution was transferred to a shake flask containing 100 mL of LB liquid medium (50 μg / mL kanamycin) and cultured until OD 600 The value was 0.8, and the bacteria were collected by centrifugation after induction at 20℃ for 20h.
[0047] The collected wet bacteria were resuspended in 250mM Tris-HCl with a pH of 7.4 to a final concentration of 10g / L, and 250mM Tris-HCl with a pH of 7.4 was used as the buffer system. 10mM L-piperidinic acid, 10mM α-ketoglutaric acid, 1mM ferrous sulfate and 5mM ascorbic acid were added to form a transformation system of 1mL. The reaction was carried out at 30°C and 800rpm. The reaction was completed for 40min. The reaction system was centrifuged at 4°C and 12000rpm for 3min. The supernatant was taken for derivatization. After the derivatization, HPLC detection was performed. The derivatization method was as follows: 100μL of the sample was diluted with 200μL of 100mM borate buffer. The diluted sample was derivatized with 10mM Fmoc-Cl in acetonitrile (300μL), mixed vigorously, and reacted at 25°C for 40min. The mixture was quenched with 600 μL of 25% acetonitrile / 250 mM borate buffer to terminate the reaction.
[0048] Table 2: Specific enzyme activity data of cis-4-proline hydroxylase from different sources
[0049]
[0050]
[0051] in:
[0052] Enzyme activity definition: The amount of cells required to generate 1 micromole of cis-5-hypip per minute at 30°C and pH 7.4 is defined as one enzyme activity unit, U.
[0053] Specific enzyme activity is defined as the number of activity units per gram of cells, U / g.
[0054] Example 4: Synthesis of cis-5-hypip using XdP4H as a biocatalyst in an aqueous system at 30°C with 10 mM L-piperidinic acid as substrate
[0055] According to the method in Example 3, the XdP4H wet cells were obtained, and the collected wet cells were resuspended in 250mM Tris-HCl at pH 7.4 to a final concentration of 25g / L, and 250mM Tris-HCl at pH 7.4 was used as a buffer system, and 10mM L-piperidinic acid, 20mM α-ketoglutaric acid, 2mM ferrous sulfate and 10mM ascorbic acid were added to form a conversion system of 10mL, and the reaction was carried out at 30°C and 600rpm. The reaction was completed for 3h, and the reaction system after the reaction was placed at 4°C and 12000rpm for centrifugation for 3min. The derivatization method was consistent with Example 3. After the reaction was completed, the concentration of cis-5-hypip was 696.59μM, the concentration of cis-3-hypip was 70.47μM, and the purity of cis-5-hypip was 91.94% by HPLC.
[0056] Example 5: Synthesis of cis-5-hypip using KjP4H as a biocatalyst in an aqueous system at 30°C with 10 mM L-piperidinic acid as substrate
[0057] KjP4H wet cells were obtained according to the method in Example 3, and the collected wet cells were resuspended in 250mM Tris-HCl at pH 7.4 to a final concentration of 25g / L, and 250mM Tris-HCl at pH 7.4 was used as a buffer system, and 10mM L-piperidinic acid, 20mM α-ketoglutaric acid, 2mM ferrous sulfate and 10mM ascorbic acid were added to form a conversion system of 10mL, and the reaction was carried out at 30°C and 600rpm. The reaction was completed for 3h, and the reaction system after the reaction was placed at 4°C and 12000rpm for centrifugation for 3min. The derivatization method was consistent with Example 3. After the reaction was completed, the concentration of cis-5-hypip was 8641.32μM, the concentration of cis-3-hypip was 540.27, and the purity of cis-5-hypip was 94.12% by HPLC.
[0058] Example 6: Synthesis of cis-5-hypip using SruP4H as a biocatalyst in an aqueous system at 30°C with 10 mM L-piperidinic acid as substrate
[0059] SruP4H wet cells were obtained according to the method in Example 3, and the collected wet cells were resuspended in 250mM Tris-HCl at pH 7.4 to a final concentration of 25g / L, and 250mM Tris-HCl at pH 7.4 was used as a buffer system, and 10mM L-piperidinic acid, 20mM α-ketoglutaric acid, 2mM ferrous sulfate and 10mM ascorbic acid were added to form a conversion system of 10mL, and the reaction was carried out at 30°C and 600rpm. The reaction was completed for 3h, and the reaction system was placed at 4°C and 12000rpm for centrifugation for 3min. The derivatization method was consistent with Example 3. After the reaction was completed, the concentration of cis-5-hypip was 6747.71μM, the concentration of cis-3-hypip was 1057.10μM, and the purity of cis-5-hypip was 86.82% by HPLC.
[0060] Example 7: Synthesis of cis-5-hypip using SmlP4H as a biocatalyst in an aqueous system at 30°C with 10 mM L-piperidinic acid as substrate
[0061] SmlP4H wet cells were obtained according to the method in Example 3, and the collected wet cells were resuspended in 250mM Tris-HCl at pH 7.4 to a final concentration of 25g / L, and 250mM Tris-HCl at pH 7.4 was used as a buffer system, and 10mM L-piperidinic acid, 20mM α-ketoglutaric acid, 2mM ferrous sulfate and 10mM ascorbic acid were added to form a conversion system of 10mL, and the reaction was carried out at 30°C and 600rpm. The reaction was completed for 3h, and the reaction system was placed at 4°C and 12000rpm for centrifugation for 3min. The derivatization method was consistent with Example 3. After the reaction was completed, the concentration of cis-5-hypip was 2695.43μM, the concentration of cis-3-hypip was 1924.25μM, and the purity of cis-5-hypip was 58.35% by HPLC.
Claims
1. A cis-4-proline hydroxylase, characterized in that The amino acid sequence of the cis-4-proline hydroxylase is shown in SEQ ID NOs. 1 to 8; the nucleotide sequence of the gene encoding the cis-4-proline hydroxylase is shown in SEQ ID NOs. 9 to 16.
2. A cis-4-proline hydroxylase according to claim 1, characterized in that The cis-4-proline hydroxylase is derived from any one of Mesorhizobium sp., Sinorhizobium meliloti (Rhizobium meliloti), Mesorhizobium japonicum, Kordia jejudonensis, Sinorhizobium meliloti, Micromonospora chokoriensis, Xenorhabdus doucetiae, and Segniliparus rugosus.
3. A recombinant vector, characterized in that: The recombinant vector contains the coding gene according to claim 1.
4. A genetically engineered bacterium, characterized in that: The recombinant vector according to claim 3 is introduced into the genetically engineered bacteria.
5. Use of the cis-4-proline hydroxylase according to any one of claims 1 to 2 in the preparation of cis-L-5-hydroxy-piperidine-2-carboxylic acid.
6. The use according to claim 5, characterized in that: L-piperidinic acid is used as a substrate, α-ketoglutaric acid is used as a cosubstrate, and the cis-4-proline hydroxylase described in any one of claims 1 to 2 is used as a catalyst. A catalytic reaction is carried out in a system containing ferrous salt, an antioxidant and a buffer to synthesize cis-L-5-hydroxy-piperidine-2-carboxylic acid.
7. The use according to claim 6, characterized in that: The amount of cis-4-proline hydroxylase added does not exceed 10w% of the reaction system.
8. The use according to claim 6, characterized in that: The ferrous salt is selected from one or more of ferrous chloride, ferrous sulfate, and ammonium ferrous nitrate.
9. The use according to claim 6, characterized in that: The antioxidant is selected from at least one of ascorbic acid and ascorbate.
10. The use according to claim 6, characterized in that: The temperature of the catalytic reaction is 25-55° C.; the pH of the catalytic reaction is 6.0-7.5.
Citation Information
Cited By
PET pretreatment method and application of PET pretreatment method in promotion of bacterial degradation
CN121450503A
